At the molecular level, clinical hypercontractility associated with many hypertrophic cardiomyopathy (HCM)-causing mutations in β-cardiac myosin appears to be driven by their disruptive effect on the ...
Heart Failure (HF) is the inability of the heart to pump sufficient blood across the body to meet tissue requirements. Slow health decline poses a significant challenge for patient management and ...